Significance of testing for TP53 gene mutations in lung adenocarcinoma using targeted gene sequencing.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2018.10.66
Abstract: Randomized clinical trials have demonstrated the positive effects of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for patients with advanced or recurrent lung adenocarcinomas harboring EGFR gene mutations (1-3). Detecting cancer-specific gene mutations and exploring… read more here.
Keywords: gene mutations; mutations lung; significance testing; tp53 gene ... See more keywords